Showing 15 posts of 42 posts found.


Novartis nets first acute myeloid leukaemia approval in Canada, but NICE says no

December 6, 2017
Research and Development, Sales and Marketing Canada, NICE, Novartis, Rydapt, UK, acute myeloid leukaemia, leukaemia, pharma

Novartis is celebrating the news that its drug Rydapt (midostaurin) has been awarded marketing approval in Canada for the treatment …


Decade lifespan difference in Americans and Canadians with cystic fibrosis

March 15, 2017
Research and Development Canada, United States, cystic fibrosis

A new study has emerged looking into life expectancy of those with cystic fibrosis, funded by the US Cystic Fibrosis …


Quark to set up “largest biotechnology fund in Canada” for $500m

October 18, 2016
Manufacturing and Production, Research and Development Canada, Quark Venture, Vancouver, fund

Canadian venture capital firm Quark Venture is to partner up with China’s GF Securities to launch a “largest of its …


Valeant plots significant investment in Canadian operations

June 20, 2016
Manufacturing and Production, Sales and Marketing Canada, Valeant, manufacturing

Valeant Pharmaceuticals (NYSE: VRX) has announced that it plans to expand its Canadian operations with a $27.5 million expansion of …

Raptor’s Procysbi gets Priority Review from Health Canada

March 22, 2016
Manufacturing and Production, Research and Development Canada, Health Canada, Procysbi, Raptor Pharmaceutical, genetic condition

Raptor Pharmaceutical (Nasdaq: RPTP) said Canadian regulators have accepted a priority review for its drug to treat a rare genetic …

Mylan image

Mylan launches digital adherence programme for heart patients

November 27, 2015
Medical Communications Canada, Mavik, Mylan, pharmacies, trandolapril

Mylan has launched an innovative digital medication adherence and engagement program for patients with high blood pressure. The digital programme, called …


Alexion to challenge Canadian price of Soliris in court

September 28, 2015
Sales and Marketing Alexion, Canada, Drug pricing, Patented Medicine Prices Review Board, eculizumab, soliris

Alexion Pharmaceuticals is taking the Canadian government to court for its attempt to lower the price of the rare disease …


Medicago invests big into plant-based vaccines

May 26, 2015
Manufacturing and Production, Sales and Marketing Canada, Quebec, medicago, vaccines

Canadian biotech Medicago is building a $245 million new production complex in Quebec to make more vaccines and therapeutics based …

Valeant image

Valeant sprints ahead of Endo to secure Salix

March 18, 2015
Sales and Marketing Actavis, Canada, Endo, Valeant, Xifaxan, methylnaltrexone, rifaximin, salix

Salix Pharmaceuticals has accepted an improved $11.1 billion takeover swoop from Valeant Pharmaceuticals to beat rival bidder Endo International. The …

allergan image

Actavis buys Allergan for $66 billion

November 18, 2014
Medical Communications, Sales and Marketing Actavis, Allergan, Botox, Canada, Valeant, merger

The stately dance between Actavis and Allergan has culminated in the former buying the Botox manufacturer in a $66 billion …

Pfizer image

Pfizer partners with MedGenesis on Parkinson’s

September 16, 2014
Research and Development, Sales and Marketing Canada, Erich Mohr, MedGenesis, Parkinson's, Parkinson’s, Pfizer, neuroscience

Canadian biotech MedGenesis has entered into an agreement with Pfizer to develop potential treatments for Parkinson’s disease. The privately-held biotech …

GSK image

GSK manufacturing woes continue

July 8, 2014
Manufacturing and Production Canada, FDA, GSK, Paxil, Vaccine, manufacturing

Health Canada has told GlaxoSmithKline that it wants to see the firm fix major problems at the country’s only flu …

Novartis image

Novartis shuts plant in Canada cutting 300 jobs

December 16, 2013
Manufacturing and Production, Sales and Marketing Canada, Novartis, Ontario, cuts, lens, manufacturing

Novartis is shutting down its manufacturing plant in Canada which will result in 300 people losing their jobs at the …

Canada image

Canada tightens GMP rules for active ingredients

May 21, 2013
Manufacturing and Production API, Canada, GMP

Canada’s Food and Drug Regulations have been amended to extend the requirements for Good Manufacturing Practices (GMP) to active pharmaceutical …

Latest content